Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.

MLA

Tamaki, Yuichiro, et al. “Association between Cancer Risk and Drug-Metabolizing Enzyme Gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) Polymorphisms in Cases of Lung Cancer in Japan.” Drug Metabolism and Pharmacokinetics, vol. 26, no. 5, 2011, pp. 516–22. EBSCOhost, https://doi.org/10.2133/dmpk.dmpk-11-rg-046.

APA

Tamaki, Y., Arai, T., Sugimura, H., Sasaki, T., Honda, M., Muroi, Y., Matsubara, Y., Kanno, S., Ishikawa, M., Hirasawa, N., & Hiratsuka, M. (2011). Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metabolism and Pharmacokinetics, 26(5), 516–522. https://doi.org/10.2133/dmpk.dmpk-11-rg-046

Chicago

Tamaki, Yuichiro, Tomio Arai, Haruhiko Sugimura, Takamitsu Sasaki, Masashi Honda, Yuka Muroi, Yoichi Matsubara, et al. 2011. “Association between Cancer Risk and Drug-Metabolizing Enzyme Gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) Polymorphisms in Cases of Lung Cancer in Japan.” Drug Metabolism and Pharmacokinetics 26 (5): 516–22. doi:10.2133/dmpk.dmpk-11-rg-046.